Search results
Results from the WOW.Com Content Network
Urethral cancer is a rare cancer originating from the urethra.The disease has been classified by the TNM staging system and the World Health Organization. [1] [3] [4]Symptoms include blood in the urine, lump at end of penis, or bloody penile discharge.
Transitional cell carcinoma is a type of cancer that arises from the transitional epithelium, a tissue lining the inner surface of these hollow organs. [1] It typically occurs in the urothelium of the urinary system; in that case, it is also called urothelial carcinoma.
Ureter cancer rarely causes problems in the early stages, but as the cancer progresses, there are often side effects. [5] Symptoms of ureteral cancer may include "blood in the urine (); diminished urine stream and straining to void (caused by urethral stricture); frequent urination and increased nighttime urination (); hardening of tissue in the perineum, labia, or penis; itching; incontinence ...
Bladder cancer is most common in wealthier regions of the world, where exposure to certain carcinogens is highest. It is also common in places where schistosome infection is common, such as North Africa. [47] Bladder cancer is much more common in men than women; around 1.1% of men and 0.27% of women develop bladder cancer. [2]
Uriniferous tubules: any of the small tubules that are the excretory units of the vertebrate kidney; Uveoscleral pathway: a tubule that drains excess aqueous humor; Vasa efferentia: convoluted tubules that lead from the rete testis to the vas deferens and form the head of the epididymis [2]
Kidney cancer, also known as renal cancer, is a group of cancers that starts in the kidney. [4] Symptoms may include blood in the urine, a lump in the abdomen, or back pain. [1] [2] [3] Fever, weight loss, and tiredness may also occur. [1] [2] [3] Complications can include spread to the lungs or brain. [6]
For premium support please call: 800-290-4726 more ways to reach us
Compared to other common types of RCC, PRCC exhibits a relatively lower risk of tumor recurrence and cancer-related death after nephrectomy. [48] Specifically, the cancer-specific survival rate at five years following surgery with PRCC has reached up to 91%, while clear cell RCC and chromophobe RCC were 72% and 88%, respectively. [46]